Revenue
2022
2023
2024
2025
Haoxi Health Technology Ltd (HAO)
Price$3.39Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $537,646 | $1.2M | $28.2M | $16.2M |
| Gross profit | $927,750 | $2.8M | $2.1M | $648,721 |
| Gross margin | 172.56% | 232.07% | 7.30% | 4.02% |
| Research & development | $79,544 | $79,985 | $58,161 | $102,524 |
| Operating expenses | $2.9M | $1.0M | $866,255 | $379,953 |
| Operating income | −$2.0M | $1.7M | $1.2M | $268,768 |
| Operating margin | −371.97% | 144.90% | 4.24% | 1.66% |
| EBITDA | −$1.6M | $1.7M | $1.2M | $270,980 |
| EBITDA margin | −302.83% | 145.79% | 4.27% | 1.68% |
| Net income | $3.9M | $1.3M | $969,752 | $244,587 |
| Net profit margin | 721.05% | 108.99% | 3.44% | 1.51% |
| Basic EPSper basic share | $1.66 | $1.06 | $0.87 | $0.01 |
| Diluted EPSper diluted share | $1.32 | $1.06 | $0.87 | $0.01 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Marex Group Ltd | 38.08K |
Virtu Financial LLC | 11.62K |
XTX Topco Ltd | 10.73K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026Form 4 | Fan ZhenCEO & Chairman | BuyClass B Ordinary Shares | 40.00M | $0.02 | $800.0K | 40.69M |